CD8A and neoplasm: To determine functional activity of these cells, DCs were isolated from draining lymph nodes of MC38 tumor-bearing mice following 7 days of 25 mg/kg b.i.d. ceralasertib treatment and used for stimulation of allogenic CD4+ or CD8+ T-cells.